NHS COULD SAVE £120 MILLION WITH GENERIC HIP IMPLANTS NOW AVAILABLE )(Orthimo)
See more stories about Generics
The NHS could be set to deliver some of the savings set out in Lord Carter’s recent review of spending, with new devices introduced into the health system.
This week, generic hip implants have become available through the NHS Supply Chain. This ensures that NHS hospitals now have access to high quality, less expensive orthopaedic implants.
Created by Manchester-based company Orthimo, these Optimised Equivalent® prostheses have been developed based on evidence from over one million of the best performing hip implants.
The UK is the first country in the world to benefit from applying the principle of generics to orthopaedic products. Generic medicines have been a core part of the NHS since the 1980s, offering the same clinical outcomes for patients as originator drugs, and now contributing over £12 billion in savings every year that can be reinvested into the health service.1
With over 66,000 hip replacement operations performed by the NHS every year,2 switching to generic hip implants from the current market leaders, the NHS could save up to £120 million by 2020 - enough to...
